HK1222336A1 - 包含膽鹼及其衍生物的組合物、其用途以及其製備方法 - Google Patents

包含膽鹼及其衍生物的組合物、其用途以及其製備方法

Info

Publication number
HK1222336A1
HK1222336A1 HK16110609.4A HK16110609A HK1222336A1 HK 1222336 A1 HK1222336 A1 HK 1222336A1 HK 16110609 A HK16110609 A HK 16110609A HK 1222336 A1 HK1222336 A1 HK 1222336A1
Authority
HK
Hong Kong
Prior art keywords
choline
derivatives
compositions
processes
preparation
Prior art date
Application number
HK16110609.4A
Other languages
English (en)
Inventor
Asher Widberg
Ran Numa
Gai Ben-Dror
Fabiana Bar-Yoseph
Original Assignee
Enzymotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzymotec Ltd filed Critical Enzymotec Ltd
Publication of HK1222336A1 publication Critical patent/HK1222336A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK16110609.4A 2013-10-21 2016-09-06 包含膽鹼及其衍生物的組合物、其用途以及其製備方法 HK1222336A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361893307P 2013-10-21 2013-10-21
US201361893308P 2013-10-21 2013-10-21
PCT/IL2014/050912 WO2015059697A1 (en) 2013-10-21 2014-10-21 Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation

Publications (1)

Publication Number Publication Date
HK1222336A1 true HK1222336A1 (zh) 2017-06-30

Family

ID=51999472

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16110609.4A HK1222336A1 (zh) 2013-10-21 2016-09-06 包含膽鹼及其衍生物的組合物、其用途以及其製備方法

Country Status (11)

Country Link
US (1) US20160243061A1 (zh)
EP (1) EP3060202A1 (zh)
JP (1) JP2016535734A (zh)
KR (1) KR20160075524A (zh)
CN (1) CN105682481A (zh)
AU (1) AU2014338503A1 (zh)
HK (1) HK1222336A1 (zh)
IL (1) IL244484A0 (zh)
MX (1) MX2016003207A (zh)
SG (1) SG11201602066RA (zh)
WO (1) WO2015059697A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016170388A1 (en) * 2015-04-21 2016-10-27 Enzymotec Ltd. Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation
CN108813628A (zh) * 2018-05-23 2018-11-16 青岛大学 一种防治帕金森病食用组合物的制备方法
CN108813453A (zh) * 2018-05-23 2018-11-16 青岛大学 一种防治帕金森病的食用组合物
US20210212936A1 (en) * 2018-06-01 2021-07-15 Baxter International Inc. Parenteral nutrition formulation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2864848A (en) 1954-07-19 1958-12-16 Ca Nat Research Council Method of producing l-alpha-glycerylphosphorylcholine
US3475177A (en) * 1966-02-09 1969-10-28 Commercial Solvents Corp Choline composition
JPS62111926A (ja) * 1985-11-11 1987-05-22 Nippon Oil & Fats Co Ltd コリン作働性神経系活性化剤
JPH0656671A (ja) * 1992-08-04 1994-03-01 Nippon Oil & Fats Co Ltd 機能性食品
CN1115217A (zh) * 1994-07-22 1996-01-24 戴根春 鸡蛋保健品的制造方法
US6013273A (en) * 1997-01-27 2000-01-11 Novartis Nutrition Ag Treatment of endotoxic shock
US20040043013A1 (en) * 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US20030206881A1 (en) * 2001-05-31 2003-11-06 Peter Fussbroich Phospholipidic composition as well as the use thereof
AU2004257756A1 (en) * 2003-07-10 2005-01-27 Carl A. Forest Foods, beverages, condiments, spices and salad dressings with specialized supplements
AU2006270921A1 (en) 2005-07-19 2007-01-25 Asahi Kasei Pharma Corporation Novel phospholipid processing agent
JP5300186B2 (ja) * 2006-08-23 2013-09-25 株式会社明治 血中ホモシステイン濃度の上昇を抑制する妊婦用の乳由来組成物
EP2076244B1 (en) * 2006-10-10 2016-12-07 Jina Pharmaceuticals Inc. Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof
CA2609580A1 (en) * 2006-12-06 2008-06-06 H3 Formulations Ltd. Composition for promoting cognitive attributes
JP2009155337A (ja) * 2009-03-31 2009-07-16 Tsujido Chemical Corp 治療剤
WO2010146831A1 (en) * 2009-06-16 2010-12-23 Meiji Dairies Corporation Prenatal milk-derived composition for preventing the risk of low birthweight of newborns
JP5896474B2 (ja) * 2010-12-29 2016-03-30 株式会社 西崎創薬研究所 認知機能改善用併用剤
ITGE20110050A1 (it) * 2011-04-29 2012-10-30 Marco Zipoli Alimento, in particolare una bevanda per l'alimentazione umana
CN102516292B (zh) * 2011-11-08 2014-09-10 西北大学 一种天然L-α-甘油磷脂酰胆碱及其制备方法
CN102964377B (zh) * 2012-11-30 2015-05-27 西北大学 一种天然L-α-甘油磷脂酰胆碱的制备方法
EP2859889A1 (en) * 2013-10-14 2015-04-15 Abbott Laboratories Compositions and methods for improving cognitive function

Also Published As

Publication number Publication date
CN105682481A (zh) 2016-06-15
EP3060202A1 (en) 2016-08-31
IL244484A0 (en) 2016-04-21
MX2016003207A (es) 2016-08-11
AU2014338503A1 (en) 2016-03-31
SG11201602066RA (en) 2016-04-28
KR20160075524A (ko) 2016-06-29
JP2016535734A (ja) 2016-11-17
US20160243061A1 (en) 2016-08-25
WO2015059697A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
IL285390A (en) Arylquinazolines, their preparation and pharmaceutical preparations containing them
IL288961A (en) Pharmaceutical preparations
IL243752A0 (en) Multispecific antibodies, preparations containing them and their uses
IL241355A0 (en) Pyrazole-amide compounds, preparations containing them and their uses
PL2943181T3 (pl) Kompozycje farmaceutyczne
HK1222563A1 (zh) 藥物組合物、製備及其用途
HK1210806A1 (zh) 含免疫細胞組合物的製造方法及癌治療用組合物
ZA201408333B (en) Pharmaceutical compositions
IL246406A0 (en) History of imidazopyrazinone, their preparation and pharmaceutical preparations containing them
HK1216839A1 (zh) 調整釋放製劑
EP2941418A4 (en) N1-CYCLIC AMIN-N5 SUBSTITUTED BIGUANIDE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH
HK1222336A1 (zh) 包含膽鹼及其衍生物的組合物、其用途以及其製備方法
IL233682A0 (en) Modified phenylazole derivatives, preparations containing them and their uses
IL239873B (en) The history of piperidinylcarbazole, their preparation and pharmaceutical preparations containing them
IL239874A0 (en) History of acylguanidine, their preparation and pharmaceutical preparations containing them
HRP20171888T1 (hr) Farmaceutski pripravci
EP3057972A4 (en) Novel compositions, uses and methods for their preparation
EP2945703A4 (en) ALBU-BCHE FORMULATIONS, PREPARATION THEREOF AND USES THEREOF
IL284405A (en) Pharmaceutical composition, preparation and uses thereof
GB201304699D0 (en) Pharmaceutical compositions
GB201321497D0 (en) Pharmaceutical compositions
GB201312851D0 (en) Pharmaceutical compositions